INSIGHTS ON CLINICAL TRIAL PARTNERING

• Key Strategies For Clinical Development In Rare Cancers

  Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.

• Are You Paying Participants Enough? Your Top Questions Answered

  Explore key themes surrounding payments to clinical research participants in depth, with a particular focus on the role of participant compensation and best practices in payment logistics.

• Can Patient Liaison Services Transform Clinical Research Access?

  Patients often face invisible hurdles in research. Watch how Patient Liaison services can change the journey for participants, sites, and sponsors, making trials easier to join and stay in.

• Five Ways Site-Facing Technology Helps Sponsors And CROs

  Site-facing technology is presented as a crucial enabler of efficient trial execution, aligning site operations with sponsor timelines and objectives.

•  Life Sciences Meetings Need More Than Logistics

  8/6/2026

  Life sciences meetings often extend beyond investigators’ meetings. Strong planning helps teams support clinical, commercial, governance, and internal programs without adding pressure to the host team.

• Korio RTSM Platform: Site User Experience

  3/18/2026

  With minimal navigation, users of this platform can view a participant list, demographics, and status indicators — taking key actions like screening or randomizing without leaving the main grid.

• Site Initiation Visits For Clinical Trials: Ocular Endpoint Planning For Sponsors And CROs

  2/5/2026

  Learn how expert site initiation visit (SIV) planning masters complex endpoints like OCT and BCVA, eliminates data variability, and prevents the costly need for trial rescue.

• Why ddPCR Is Becoming The Standard For Gene Therapy Biodistribution

  3/9/2026

  ddPCR is becoming essential for biodistribution because it delivers precise, low‑copy quantification qPCR can’t reliably match. Sponsors need partners with true ddPCR depth to ensure consistent, defensible data across tissues and studies.

• Faster Trial Planning and Site Selection

  4/15/2025

  Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.